Frank Rimerman Advisors LLC Purchases 1,794 Shares of CME Group Inc. $CME

Frank Rimerman Advisors LLC increased its position in shares of CME Group Inc. (NASDAQ:CME) by 11.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,953 shares of the financial services provider’s stock after acquiring an additional 1,794 shares during the period. Frank Rimerman Advisors LLC’s holdings in CME Group were worth $4,673,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of CME. Mount Lucas Management LP bought a new position in shares of CME Group in the second quarter worth $1,368,000. Slagle Financial LLC purchased a new position in CME Group during the second quarter worth about $3,536,000. Raiffeisen Bank International AG grew its position in CME Group by 2.6% during the second quarter. Raiffeisen Bank International AG now owns 4,795 shares of the financial services provider’s stock worth $1,309,000 after buying an additional 121 shares in the last quarter. Symphony Financial Ltd. Co. bought a new position in CME Group in the 2nd quarter worth about $43,376,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in shares of CME Group by 31.1% in the 2nd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 398,743 shares of the financial services provider’s stock valued at $109,902,000 after acquiring an additional 94,659 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 14,043 shares of company stock valued at $3,791,486. 0.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

CME has been the subject of a number of research reports. Rothschild & Co Redburn boosted their price target on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research note on Thursday, November 6th. UBS Group reduced their target price on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday, October 23rd. TD Cowen raised their price target on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research report on Thursday, October 23rd. Piper Sandler upped their price objective on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Finally, JPMorgan Chase & Co. raised their price objective on CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a report on Tuesday, October 14th. Eight research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $287.65.

CME Group Stock Down 2.1%

Shares of NASDAQ:CME opened at $279.13 on Tuesday. The stock has a market capitalization of $100.65 billion, a P/E ratio of 27.05, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. The stock’s 50-day moving average price is $267.66 and its 200-day moving average price is $272.83. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $224.62 and a 12-month high of $290.79.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company posted $2.68 EPS. CME Group’s revenue for the quarter was down 3.0% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio is 48.45%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.